Azelis Group (AZE) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
16 Nov, 2025Executive summary
Revenue reached €2.2bn in H1 2025, up 0.6% year-over-year, with 1.2% organic growth and 2.2% from acquisitions, offset by FX headwinds and market volatility.
EMEA delivered strong growth, offsetting slowdowns in the U.S. and APAC; business model resilience supported by higher cash flows despite margin compression.
Free cash flow grew 10.8% to €151m, with cash conversion improving by over 10 percentage points to 63.8%.
Three acquisitions (Solchem, S Amit, ACEF) expanded presence in Spain, India, and Italy, with combined 2024 revenue over €100m.
Strategic focus remains on innovation, sustainability, digitalization, and cost savings to drive long-term value.
Financial highlights
H1 2025 revenue: €2.2bn (+0.6% year-over-year, +1.2% organic); gross profit €515m, down 2.2%, with margin at 23.9%.
Adjusted EBITA/EBITDA margin at 10.9%, with adjusted EBITA down 7.7% to €234m.
Net profit for H1 2025 was €85.5m, down 14.6% year-over-year.
Free cash flow of €151m, with an 11 percentage point increase in cash conversion ratio to 63.8%.
Net financial expense decreased 3.4% to €69.9m; effective tax rate at 29%.
Outlook and guidance
Macro uncertainty from tariffs, geopolitical instability, and regional conflicts continues to weigh on demand.
Cost-saving program (annualized run-rate €20m) to deliver half of savings in H2 2025; focus on cost control and cash preservation.
Asset-light model and disciplined cost/working capital management to support resilience and cash generation.
Long-term sector fundamentals remain attractive; M&A to resume once leverage stabilizes.
Strong positioning to capitalize on industry shifts, supported by global presence and alignment with demand trends.
Latest events from Azelis Group
- Revenue up 1.3% to €4.1bn, but net profit fell 40% as cash flow and leverage rose.AZE
H2 202519 Feb 2026 - Stable revenue, margin gains, and acquisitions amid profit and cash flow pressure.AZE
H1 20242 Feb 2026 - Q3 2024 saw organic growth and margin gains, with acquisitions driving resilient performance.AZE
Q3 2024 TU18 Jan 2026 - Revenue and margins improved in 2024, with strong M&A activity and positive outlook for 2025.AZE
H2 202425 Dec 2025 - Revenue up 4.5% to EUR 1.1bn, but margin pressure led to cost-saving measures.AZE
Q1 2025 TU29 Nov 2025 - Free cash flow up 34% and margin pressure, with four acquisitions and higher leverage.AZE
Q3 2025 TU23 Oct 2025 - Azelis drives growth and innovation in specialty chemicals distribution with strong financial returns.AZE
Investor Lab Tour 2024 Istanbul Presentation13 Jun 2025